Alcohol drinking and cardiac risk

Nutrition Research Reviews

Volumn 15, Issue 1, 2002, Pages 91-121

  Buemann, Benjamin ^a   Dyerberg, Jørn ^a   Astrup, Arne ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Alcohol; Alcoholic beverage; Antioxidants; Blood lipids; Cardiovascular disease; Haemostasis

Indexed keywords

ALCOHOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYPHENOL;

ALCOHOL CONSUMPTION; ANTIOXIDANT ACTIVITY; BEER; BEVERAGE; CARDIOVASCULAR DISEASE; CONCENTRATION RESPONSE; DISEASE ASSOCIATION; DRINKING BEHAVIOR; ENDOTHELIUM CELL; HEART DISEASE; HEART PROTECTION; HUMAN; LIPID BLOOD LEVEL; MACROPHAGE ACTIVATION; OBESITY; REVIEW; WINE;

EID: 0036269446     PISSN: 09544224     EISSN: None     Source Type: Journal    
DOI: 10.1079/nrr200235     Document Type: Review

References (182)

1. Comparison of plasminogen activator inhibitor-1 concentration in insulin-resistant versus insulin-sensitive healthy women
2. Biphasic effects of repeated alcohol intake on 24-hour blood pressure in hypertensive patients
3. Moderate alcohol consumption and risk of heart failure among older persons
4. Effect of alcohol abstinence on blood pressure. Assessment by 24-hour ambulatory blood pressure monitoring
5. Alcohol consumption and risk of type 2 diabetes mellitus among US male physicians
6. Moderate alcohol consumption and the risk of sudden cardiac death among US male physicians
7. Heart rate variability from 24-hour electrocardiography and the 2-years risk for sudden death
8. Moderate alcohol consumption increases plasma high-density lipoprotein cholesterol
9. Effects of alcohol use and other aspects of lifestyle on blood pressure levels and prevalence of hypertension in a working population
10. Alcohol consumption, smoking habits and body fat distribution in Italian men and women aged 20-60 years
11. Alcohol impairs insulin sensitivity in normal subjects
12. Effects of ethanol on lipid metabolism
13. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors
14. Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics
15. Effect of red and white wine on serum lipids, platelet aggregation, oxidation products and antioxidants
16. Effect of beer drinking on risk of myocardial infarction: Population based case-control study
17. Absorption of ferulic acid from low-alcohol beer
18. Homocysteine and cardiovascular disease: Cause or effect?
19. The Tromsø heart study: Alcoholic beverage and coronary risk factors
20. Alcohol and high-density-lipoprotein cholesterol: A randomized controlled trial
21. Serum antioxidant capacity is increased by consumption of strawberries, spinach, red wine or vitamin C in elderly women
22. Upper body fat distribution: A hyperinsulinemia-independent predictor of coronary heart disease mortality. The Paris prospective study
23. Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway
24. Role of hydroxyl radical in silica-induced NF-κB activation in macrophages
25. Fasting serum insulin in relation to components of the metabolic syndrome in European healthy men: The European Fat Distribution Study
26. Moderate alcohol consumption and its relation to visceral fat and plasma androgens in healthy women
27. Wine, beer and spirits and the risk of myocardial infarction: A systematic review
28. Homocysteine, a risk factor for coronary artery disease or not? A meta-analysis
29. Implications of small reductions in diastolic blood pressure for primary prevention
30. Blood pressure and its relationship to low levels of alcohol consumption
31. Influence of moderate daily wine consumption on body weight regulation and metabolism in healthy free-living males
32. Influence of moderate chronic wine consumption on insulin sensitivity and other correlates of syndrome X in moderately obese women
33. High density lipoprotein cholesterol and apoprotein A1 in healthy volunteers during long-term moderate alcohol intake
34. Effects of alcohol on plasma lipoproteins and cholesterol and triglyceride metabolism in man
35. A high-fat diet induces and red wine counteracts endothelial dysfunction in human volunteers
36. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries
37. Antioxidants and atherosclerotic heart disease
38. The effect of alcohol on coagulation and fibrinolytic factors: A controlled trial
39. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition
40. Endothelium-dependent vasorelaxing activity of wine and other grape products
41. Alcohol consumption and insulin resistance in young adults
42. Effects of red and white wine on endothelial-dependent vasorelaxation of rat aorta and human coronary arteries
43. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine
44. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation
45. Alcohol intake modulates the effect of polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and risk of myocardial infarction
46. Beer affects oxidative stress due to ethanol in rats
47. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction
48. Type of alcoholic beverage and risk of myocardial infarction
49. Antioxidant activity of different phenolic fractions separated from an Italian red wine
50. Beer increases plasma antioxidant capacity in humans
51. Relationship of alcohol intake with blood pressure in young adults
52. Alcohol and high-density lipoprotein cholesterol
53. Moderate beer consumption and positive biochemical changes in patients with coronary atherosclerosis
54. Moderate beer consumption and the blood coagulation in patients with coronary artery disease
55. The holiday heart: Elctrophysiologic studies of alcohol effects in alcoholics
56. Influence of sex, age, body mass index, and smoking on alcohol intake and mortality
57. Mortality associated with moderate intakes of wine, beer, or spirits
58. Non-high-density lipoprotein cholesterol level as potential risk predictor and therapy target
59. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
60. Effect of moderate alcohol intake on the lipoproteins of normotriglyceridemic obese subject compared with normoponderal controls
61. Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography
62. Relationship of alcohol consumption and smoking to plasma cortisol and blood pressure
63. Effects of alcohol intake on high-density lipoprotein cholesterol levels in runners and inactive men
64. Effect of alcohol dose on plasma lipoprotein subfractions and lipolytic enzyme activity in active and inactive men
65. The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions
66. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells
67. Alcohol consumption, serum low density lipoprotein cholesterol concentration, and risk of ischaemic heart disease: Six year follow up in the Copenhagen male study
68. Moderate doses of alcoholic beverages with dinner and postprandial high density lipoprotein composition
69. Effect of moderate dose of alcohol with evening meal on fibrinolytic factors
70. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study
71. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study
72. Platelet thromboxane formation and bleeding time is influenced by ethanol withdrawal but not by cigarette smoking
73. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction
74. Heart rate variability used as an arrhythmia risk stratifier after myocardial infarction
75. Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency
76. Meta-analysis of effect of high vs low vitamin E intake on cardiovascular mortality for observational and intervention studies
77. Effects of regular alcohol consumption on 24 hour ambulatory blood pressure recordings
78. Alcohol and high-density lipoprotein cholesterol. Causal inference from diverse study designs
79. Effects of acute and repeated alcohol ingestion on hypothalamic-pituitary-gonadal and hypothalamic-pituitary-adrenal functioning in normal males
80. Abdominal obesity and mortality risk among men in nineteenth-century North America
81. Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men
82. Pattern of alcohol drinking and progression of atherosclerosis
83. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)
84. Insulin sensitivity and regular alcohol consumption: Large, prospective, cross sectional population study (Bruneck study)
85. Alcohol consumption and atherosclerosis: What is the relation. Prospective results from the Bruneck Study
86. Differential regulation of NO availability from macrophages and endothelial cells by the garlic component S-allyl cysteine
87. Different effects of alcoholic beverages on experimental atherosclerosis in rabbits
88. Acute alcohol intake decreases short-term heart rate variability in healthy subjects
89. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease
90. The relationship of alcohol consumption to atherosclerotic heart disease
91. Ethyl alcohol enhances plasminogen activator secretion by endothelial cells
92. Alcohol intake and insulin levels. The Normative Ageing Study
93. Relationship between alcohol intake and tissue plaminogen activator antigen and other haemostatichemostatic factors in the general population
94. Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated
95. Alcohol, liver, and nutrition
96. Effects of a single, daily alcoholic beverage on lipid and hemostatic markers of cardiovascular risk
97. How much alcohol and how often? Population based case-control study of alcohol consumption and risk of a major coronary event
98. Effect of alcohol consumption versus abstinence on 24-h blood pressure profile in normotensive alcoholic patients
99. Free radicals as mediators of alcohol toxicity
100. Measuring plasma fibrinogen to predict stroke and myocardial infarction. An update
101. Alcohol and coronary heart disease
102. A population study of the influence of beer consumption on folate and homocysteine concentrations
103. Epidemiological characteristics of platelet aggregability
104. Fibrinogen. A possible link between alcohol consumption and cardiovascular disease
105. Metabolic effects of alcohol
106. Ethanol ingestion inhibits human whole blood platelet impedance aggregation
107. Antioxidant and prooxidant actions of prenylated and nonprenylated chalones and flavones in vitro
108. Paradoxical fate and biological actions of peroxynitrite on human platelets
109. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men
110. Alcohol and ischemic heart disease: Wine, beer or both?
111. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins
112. Effects of alcohol on lipoprotein lipase, hepatic lipase, cholesteryl ester transfer protein, and lecithin: Cholesterol acyltransferase in high-density lipoprotein cholesterol elevation
113. Effects of alcohol and the evening meal on shear-induced platelet aggregation and urinary excretion of protanoids
114. The effect of acute ingestion of a large dose of alcohol on the hemostatic system and its circadian variation
115. The effects of short-term alcohol intake on clinic and ambulatory blood pressure in normotensive social drinkers
116. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease
117. Wines and grape juices as modulators of platelet aggregation in healthy human subjects
118. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis
119. HDL cholesterol and mortality in Finnish Men with special reference to alcohol intake
120. Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers
121. Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells. A possible mechanism for the cardiovascular benefits associated with moderate consumption of wine
122. Protective study of risk factors for development of non-insulin dependent diabetes in middle aged British men
123. Effects of moderate alcohol consumption on platelet aggregation, fibrinolysis, and blood lipids
124. Alcohol and obesity
125. Effect of alcohol on sleep and night time growth hormone and cortisol concentrations
126. Influence of pattern of alcohol intake on blood pressure in regular drinkers: A controlled trial
127. Effects of ethanol on pathways of platelet aggregation in vitro
128. High-density lipoproteins from human alcoholics exhibit impaired reverse cholesterol transport function
129. Moderate alcohol consumption has been shown previously to improve insulin sensitivity in men
130. Genetic screening of the lipoprotein lipase gene for mutations associated with high triglyceride/low HDL-cholesterol levels
131. Wine, alcohol, platelets, and the French paradox for coronary heart disease
132. Alcohol and platelet aggregation: The Caerphilly prospective heart disease study
133. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator
134. Prospective study of alcohol consumption and risk of coronary disease in men
135. Review of moderate alcohol consumption and reduced risk of coronary heart disease: Is the effect due to beer, wine, or spirits?
136. 6 from diet and supplements in relation to risk of coronary heart disease among women
137. Moderate alcohol intake and lower risk of coronary heart disease: Meta-analysis of effects on lipids and haemostatic factors
138. Ethanol interferes with collagen-induced platelet activation by inhibition of arachidonic acid mobilization
139. Platelet rebound effect of alcohol withdrawal and wine drinking in rats. Relation to tannins and lipid peroxidation
140. Change in women's plasma lipid and lipoprotein concentrations due to moderate consumption of alcohol are affected by dietary fat level
141. Increased high-density lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity
142. Effects of alcohol on lipoproteins in relation to coronary heart disease
143. Effect of uric acid and chemical analogues on oxidation of human low density lipoprotein
144. Alcohol-free red wine enhances plasma antioxidant capacity in humans
145. Moderate alcohol consumption is associated with decreased platelet activity in patients presenting with acute myocardial infarction
146. Alcohol decreases insulin sensitivity in healthy subjects
147. Ethanol causes acute inhibition of carbohydrate, fat, and protein oxidation and insulin resistance
148. Relationship of alcohol consumption to changes in HDL-subfractions
149. 3 cholesterol
150. Cross-sectional study of beer consumption and blood pressure in middle-aged men
151. Plasma acetate turnover and oxidation
152. Associations of body fat and its distribution with dietary intake, physical activity, alcohol, and smoking in blacks and whites
153. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction
154. Adrenocortical activation in alcoholics during chronic drinking
155. Effect of ethanol on platelet phopholipase A2
156. Effects of alcohol on energy metabolism and body weight regulation: Is alcohol a risk factor for obesity?
157. Sex differences in the relationships between obesity, alcohol consumption and cigarette smoking and serum lipid and lipoprotein concentrations in a normal population
158. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women. Evidence for the fibrinolytic system as an independent primary risk factor
159. Increased concentrations of manganese superoxide dismutase in serum of alcohol-dependent patients
160. Wine intake and diet in a random sample of 48763 Danish men and women
161. Is ethanol an important antioxidant in alcoholic beverages associated with risk reduction of cataract and atherosclerosis?
162. Acute inhibitory effect of alcohol on fibrinolysis
163. Effect of consumption of red wine, spirits, and beer on serum homocysteine
164. Moderate consumption of beer, red wine and spirits has counteracting effects on plasma antioxidants in middle-aged men
165. The role of alcohol in the anti low density lipoprotein oxidation activity of red wine
166. Differences in the association between alcohol consumption and blood pressure by age, gender, and smoking
167. Induction of net mass lipid transfer reactions in plasma by wine consumption with dinner
168. Effects of moderate alcohol consumption on platelet function, tissue-type and plasminogen activator inhibitor
169. Effects of a moderate dose of alcohol on blood lipids and lipoproteins postprandially and in the fasting state
170. Ethanol increases endothelial nitric oxide production through modulation of nitric oxide synthase expression
171. 6 on progression of subclinical atherosclerosis: A randomised, placebo-controlled trial
172. Vitamins and especially flavonoids in common beverages are powerful in vitro antioxidants which enrich lower density lipoproteins and increase their oxidative resistance after ex vivo spiking in human plasma
173. Alcohol and sudden cardiac death
174. Type of alcoholic drink and risk of major coronary heart disease events and all-cause mortality
175. Factors determining case fatality in myocardial infarction. Who dies in a heart attack?
176. Effect of red wine ingestion on the antioxidant capacity of serum
177. Relation of moderate alcohol consumption and risk of systemic hypertension in women
178. The role of oxidized LDL in atherogenesis: Immunological response and anti-phospholipid antibodies
179. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans
180. Dietary supplementation of grape polyphenols and chronic ethanol administration on LDL oxidation and platelet function in rats
181. Association of intraabdominal fat and carotid atherosclerosis in non-obese middle-aged men with normal glucose tolerance
182. Effects of acute, moderate ethanol consumption on human platelet aggregation in platelet-rich plasma and whole blood